Key Insights

Highlights

Success Rate

94% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

1.5%

3 terminated out of 203 trials

Success Rate

93.9%

+7.3% vs benchmark

Late-Stage Pipeline

2%

5 trials in Phase 3/4

Results Transparency

13%

6 of 46 completed with results

Key Signals

6 with results94% success

Data Visualizations

Phase Distribution

161Total
Not Applicable (137)
Early P 1 (1)
P 1 (5)
P 2 (13)
P 3 (2)
P 4 (3)

Trial Status

Recruiting64
Not Yet Recruiting62
Completed46
Enrolling By Invitation13
Active Not Recruiting7
Withdrawn4

Trial Success Rate

93.9%

Benchmark: 86.6%

Based on 46 completed trials

Clinical Trials (203)

Showing 20 of 20 trials
NCT07758660Phase 2Enrolling By Invitation

Alzheimer's Disease Research Center (ADRC) PET Component Study

NCT07174869CompletedPrimary

A Study To Assess The Feasibility Of Indivi Mobile Application In Monitoring Cognitive Performance In Aging Population

NCT07757542Phase 2RecruitingPrimary

Safety Assessment of H2 Inhalation in Patients With Mild Cognitive Impairment

NCT07731334Not ApplicableRecruiting

Prevalence of Mild Cognitive Impairment and Dementia in Patients Admitted to Non-neurological Rehabilitation Wards

NCT07754994Not ApplicableNot Yet RecruitingPrimary

Medication Self-Management Technology for Older Adults

NCT07225400Not ApplicableNot Yet RecruitingPrimary

Designing a Spatial Navigation Intervention Protocol Informed by Region-specific Brain Activation for Mild Cognitive Impairment

NCT07210528Phase 1Active Not RecruitingPrimary

Safety Of Nrtis for Alzheimer's Therapeutic Advancement in Singapore Study

NCT07089654Not ApplicableCompletedPrimary

Evaluation of a PMT Rehabilitation Nursing Plan for the Older Adults With MCI to Promote Cognitive Health

NCT07752316Not ApplicableCompletedPrimary

Gamma tACS to Improve Cognitive Function in Mild Cognitive Impairment

NCT07659964Not ApplicableRecruiting

Use of a Mobile Brain-Body Imaging Approach to Evaluate the Effects of Rhythmic Auditory Stimulation on Gait and Brain Function in Alzheimer's Disease

NCT07583251Phase 1RecruitingPrimary

Safety And Tolerability Of Gamma Glutamylcysteine (GGC) Oral Supplementation In MCI Patients

NCT07016178Not ApplicableCompletedPrimary

Innovative Cognitive Impairment Case Finding and Engagement for Diverse Participation in Alzheimer's Disease Care, Treatment, And Research

NCT07741773Not ApplicableNot Yet RecruitingPrimary

Assessing Treatment With High-phenolic EVOO Supplements for Neurovascular Activity

NCT07579884Phase 2Not Yet RecruitingPrimary

To Evaluate the Safety and Efficacy of RP902 Tablets

NCT07735013Not Yet RecruitingPrimary

cMIND AI Web Tool Usability Study (Hong Kong)

NCT07733726Not ApplicableEnrolling By Invitation

Oral Motor and Cognitive Dual-Task Training (OMCDT) Program for Improving Oral and Cognitive Functions Among People With Oral Frailty

NCT07731191Not ApplicableRecruitingPrimary

Digital Solutions for Predicting the Biological Mechanisms of Alzheimer's Disease Through the Analysis of Risk Factors

NCT06601933Phase 2RecruitingPrimary

Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial

NCT07441122Not ApplicableRecruitingPrimary

Enhancing Attention in Elderly Using a Brain-Computer-Interface

NCT06670807Not ApplicableRecruitingPrimary

Effect of a Probiotic Formula in Mild Cognitive Impairement

Scroll to load more

Research Network

Activity Timeline